article thumbnail

Predictors of exposure to high-priority drug-drug interactions among non-elderly adults in Quebec, Canada [Prescribing and pharmacotherapeutics]

Annals of Family Medicine

Dataset: A cohort containing a random sample of 5% of the database population of Quebec provincial administrative databases including demographic data, pharmacy claims data, medical consultations, and hospitalizations was used.

Community 130
article thumbnail

Empowerment Self-Defense Arms ED Staff Against Rising Workplace Violence

Physician's Weekly

For physicians, nurses, medical assistants, and support staff, workplace violence (WPV) is now a daily hazard, inflicting physical injury, emotional trauma, and eroding the quality of patient care. Current Responses: Necessary but Insufficient Medical organizations have responded with advocacy efforts and public campaigns.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA’s Issues Draft Guidance on Accelerated Approval: A Substantial Evidentiary and Procedural Overhaul to this High-Profile Pathway

FDA Law Blog

Since that time, it was formalized in FDA regulations (21 CFR 314 Subpart H) in 1992, codified in the Food, Drug, & Cosmetic Act by FDAMA (21 USC 356(c)) in 1997, revised by FDASIA in 2012, and described in guidance, most importantly, in the 2014 Expedited Programs for Serious Conditions Drugs and Biologics (2014 Guidance).

Clinic 64
article thumbnail

Every Day Counts for PTE: Court Finds FDA’s Reinterpretation of Testing Phase Arbitrary and Capricious

FDA Law Blog

As with other FDA-regulated products, such as human drugs and medical devices, the “regulatory review period” is composed of a “testing phase” and a “review phase.” In February 2010, an oral formulation of BRAVECTO, a medication to treat and prevent fleas and tick infestation in dogs, was the subject of an INAD submitted to the Agency.

article thumbnail

When is a Confirmatory Trial “Underway” or Conducted with “Due Diligence” Enough for Accelerated Approval? FDA Explains Its New Authorities

FDA Law Blog

For instance, the December 2024 guidance goes beyond the 2014 Expedited Programs for Serious Conditions Drugs and Biologics guidance (the last to deal substantively with accelerated approval) to describe FDAs expectation that sponsors take a proactive approach to ensuring confirmatory trials are completed within specified timelines.

IT 105
article thumbnail

Digital Skin Care: Top 8 Dermatology Apps

The Medical Futurist

SkinIO , Scanoma , Miiskin , FirstDerm , Direct Derm , iDoc24 , and SkinVision all work based on the same principle: they promise patients the option to self-check their symptoms and then to connect to a dermatologist online for consultation within a very short period of time. It’s a jackpot software for eczema troubles.

Patients 111
article thumbnail

Medical Cannabis Revisted: A Podcast with David Casarett and Eloise Theisen

GeriPal

David is a physician who wrote the book “ Stoned: A Doctor’s Case for Medical Marijuana ” and gave a TED talk on “ A Doctor’s Case for Medical Marijuana ” that was watched over 3 million times. laughter] Alex 01:39 Material here for songs related to medical marijuana or marijuana in general. Eric 01:34 Yeah.

Medical 98